January 10, 2025 - 18:55
Lucio Miele, MD, PhD, has been appointed as the new director of the LSU-LCMC Health Cancer Center, marking a significant development in the institution's commitment to advancing cancer research and treatment. Dr. Miele, a distinguished professor at LSU Health, brings a wealth of experience and expertise to his new role. His extensive background in cancer biology and clinical research positions him well to lead the center in its mission to provide innovative care and drive groundbreaking discoveries.
In his new position, Dr. Miele aims to enhance collaborative efforts between LSU and LCMC Health, focusing on improving patient outcomes and expanding access to cutting-edge therapies. His leadership is expected to foster an environment of scientific inquiry and innovation, attracting top talent and resources to the center. As the cancer landscape continues to evolve, Dr. Miele's vision for the LSU-LCMC Health Cancer Center promises to play a pivotal role in shaping the future of cancer care and research in the region.
September 14, 2025 - 02:22
John Abraham Discusses Lake Health at Minnesota State FairJohn Abraham, a professor of mechanical engineering, recently appeared on WCCO Radio during the Minnesota State Fair, where he engaged in a conversation with hosts Adam Carter and Jordana Green....
September 13, 2025 - 01:39
Vaccine Advisory Committee to Review Covid Shot Data Next WeekThe vaccine advisory committee is set to convene next week to evaluate and make recommendations regarding the updated Covid shots for the upcoming fall season. This meeting comes at a time when...
September 12, 2025 - 02:37
Exploring the Future of Women's Health ResearchWhile we understand more about women’s health than ever before, critical gaps remain. How can we delve deeper into the lifestyle and genetic factors that influence women`s health outcomes? As we...
September 11, 2025 - 01:12
New FDA Regulations Target Compounded GLP-1 Medications While Apple Expands Health FeaturesThe FDA has announced new regulations aimed at addressing the rising popularity of compounded GLP-1 medications, which have gained traction as effective treatments for obesity and diabetes. These...